| abstract |
There is provided a composition, a method, and a kit for treating cancer comprising a targeted liposome including a chemotherapeutic agent and a sensitizer for the chemotherapeutic agent, and a non-targeted liposome including an anti-angiogenic agent . In some implementations, the targeted liposomes are immunoliposomes. In another embodiment, the immuno-liposome binds to Her-2 / neu and the composition is for breast cancer treatment. |